Okay, let's tackle this question. The user is asking about an ultrasound marker associated with a greatly increased risk for Trisomy 21 in a fetus. I need to figure out which option is correct and why.

First, I remember that Trisomy 21, also known as Down syndrome, has several ultrasound markers. Common ones include nuchal translucency, echogenic intracardiac foci, short femur or humerus, and others. But which one is associated with a greatly increased risk? Nuchal translucency is a key marker. If there's an increased nuchal translucency measurement, that's a strong indicator. I think the question might be pointing towards a specific marker like nuchal edema or something similar.

Wait, the options aren't listed here. The user didn't provide the options, which is a problem. But maybe the correct answer is nuchal translucency. Let me confirm. Nuchal translucency is measured during the first trimester and is a soft marker for Down syndrome. If the measurement is above a certain threshold, the risk is significantly increased. Other markers like echogenic bowel or pyelectasis are also associated but not as strong as nuchal translucency.

The user's correct answer is probably option B, which in many questions is the nuchal translucency. But since the options aren't given, I have to proceed with the general knowledge. The core concept here is that nuchal translucency is a first-trimester ultrasound marker that correlates with aneuploidy, especially Trisomy 21. The increased fluid under the skin at the back of the neck is a sign of increased risk.

For the explanation, I need to structure it according to the user's guidelines. The core concept is about nuchal translucency as a marker. The correct answer is right because it's a well-established indicator. The wrong options would be other markers like echogenic foci or others, which are less specific. The clinical pearl is that nuchal translucency is a key marker in first-trimester screening.

I need to make sure the explanation is concise, fits within the character limit, and addresses all the required sections. Also, avoid mentioning the options since the user didn't provide them. Focus on the correct answer being nuchal translucency and explain why the others are incorrect.

**Core Concept**
Ultrasound markers for **Trisomy 21 (Down syndrome)** include **nuchal translucency**, **echogenic intracardiac foci**, and **shortened femur/humerus**. **Nuchal translucency** is the most sensitive first-trimester marker, correlating with increased fluid accumulation due to impaired lymphatic drainage in aneuploid fetuses.

**Why the Correct Answer is Right**
**Nuchal translucency** (measured between 11–14 weeks) is a **soft ultrasound marker** where increased thickness (>3.5 mm) correlates with **80–90% risk** for Trisomy 21. The mechanism involves impaired lymphatic drainage and cardiac dysfunction in aneuploid fetuses, leading to fluid accumulation in the nuchal region. This marker is central to **first-trimester combined screening** (n

✓ Correct Answer: D. Nuchal edema